Detection of non‐native species formed during fibrillization of the myocilin olfactomedin domain
Glaucoma is a group of neurodegenerative diseases that together are the leading cause of irreversible blindness worldwide. Myocilin-associated glaucoma is an inherited form of this disease, caused by intracellular aggregation of misfolded mutant myocilin. In vitro, the myocilin C-terminal olfactomedin domain (OLF), the relevant domain for glaucoma pathogenesis, can be driven to form amyloid-like fibrils under mild conditions. Here we characterize a species present during in vitro fibrillization. Purified OLF was subjected to fibrillization at concentrations required for downstream electron microscopy imaging and NMR spectroscopy. Additional biophysical techniques, including analytical ultracentrifugation and X-ray crystallography, were employed to further characterize the multicomponent mixture. Negative stain transmission electron microscopy (TEM) shows a non-native species reminiscent of known prefibrillar oligomers from other amyloid systems, NMR indicates a minor population of partially misfolded species is present in solution, and cryo-EM imaging shows two-dimensional protein arrays. The predominant soluble species remaining in solution after the fibril reaction is natively folded, as evidenced by X-ray crystallography. In summary, after incubating OLF under fibrillization-promoting conditions, there is a heterogeneous mixture consisting of soluble folded protein, mature amyloid-like fibrils, and partially misfolded intermediate species that at present belie additional molecular detail. The characterization of OLF fibrillar species illustrates the challenges associated with developing a comprehensive understanding of the fibrillization process for large, non-model amyloidogenic proteins.
Authors
- A. Grant
- Wade D. Van Horn (ORCID: https://orcid.org/0000-0002-2493-5578)
- Dustin J. E. Huard (ORCID: https://orcid.org/0000-0003-0891-4360)
- Ingeborg Schmidt‐Krey (ORCID: https://orcid.org/0000-0002-2882-9975)
- Scott M. Stagg (ORCID: https://orcid.org/0000-0001-8855-4152)
- Raquel L. Lieberman (ORCID: https://orcid.org/0000-0001-9345-3735)
- Hailee F. Scelsi (ORCID: https://orcid.org/0000-0001-5033-8550)
- Nebojša Bogdanović (ORCID: https://orcid.org/0000-0002-6811-2848)
- E. L. Dunn
- Emily G. S. Close
- Sonali H. W. Mudiyanselage
Institutions
- Florida State University (US)
- Georgia Institute of Technology (US)
- Pacific Northwest National Laboratory (US)
- Arizona State University (US)
Publication Details
- Journal
- Protein Science
- Published
- 2025-03-17
- DOI
- https://doi.org/10.1002/pro.70063
- Primary Topic
- Alzheimer's disease research and treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- U.S. Department of Energy
- National Eye Institute
- National Institute of General Medical Sciences